People: Acasti Pharma Inc (ACST.OQ)

ACST.OQ on NASDAQ Stock Exchange Capital Market

0.94USD
22 Jul 2014
Price Change (% chg)

$-0.03 (-2.95%)
Prev Close
$0.97
Open
$0.95
Day's High
$0.97
Day's Low
$0.94
Volume
25,901
Avg. Vol
46,942
52-wk High
$4.20
52-wk Low
$0.81

Search Stocks

Harland, Henri 

Brief Biography

Mr. Henri Harland serves as Secretary, Director of Acasti Pharma Ltd. He resigned as President, Chief Executive Officer of the Company effective April 28, 2014. Mr. Harland is an Actuary and holds a MBA (Finance) from Laval University. Mr. Henri Harland has been a director as well as the President and Chief Executive Officer of Neptune since its incorporation on October 9, 1998. He is the founder of the Corporation and of Neptune and has been involved in the krill research project since 1991. For more than ten years he has held the position of President and Chief Executive Officer of Gestion Harland Inc., a financial engineering group. Previously, he acted as an independent financial consultant for companies in different industrial sectors in both North America and Europe guiding them through recapitalization, financing and business development.

Basic Compensation

Total Annual Compensation, CAD Long-Term Incentive Plans, CAD All Other, CAD Fiscal Year Total, CAD
106,402 -- 368,659 475,061

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Jerald Wenker

--

Andre Godin

89,100

Pierre Lemieux

358,725

Harlan Waksal

306,533

Tina Sampalis

362,161

Henri Harland

475,061
As Of 27 Feb 2013
Search Stocks